![Andrew Allen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Allen
Directeur/Membre du Conseil chez
CULLINAN THERAPEUTICS, INC.
Fortune : - $ au 30/06/2026
Profil
Andrew R.
Allen was the founder of Nexoplex Bio, Inc., founded in 2015, serving as Director from 2024 to 2025.
Dr. Allen is the founder of Clovis Oncology, Inc., founded in 2009, serving as Chief Medical Officer & EVP-Clinical Development from 2011 to 2015.
Dr. Allen is also the founder of Revitope Oncology, Inc...
Dr. Allen is currently Chairman at Peptone Ltd. since 2023.
Dr. Allen is an Independent Director at Verge Analytics, Inc. since 2021.
Dr. Allen is Director at Cullinan Therapeutics, Inc. starting 2025.
Dr. Allen is a Member of The Royal College of Physicians.
Former positions include Independent Director at Sierra Oncology, Inc. from 2017 to 2022; Director at Nodality, Inc.; Independent Director at Epizyme, Inc. from 2014 to 2021; Director at Cell Design Labs, Inc. from 2015 to 2017; Independent Director at TCR² Therapeutics, Inc. from 2018 to 2023; Independent Non-Executive Director at Adaptimmune Therapeutics Plc from 2023 to 2025; Head-Global Project at Abbott Laboratories from 2002 to 2004; Vice President-Oncology Drug Development at Chiron Corp.
from 2004 to 2006; Chief Medical Officer & Executive VP-Clinical at Pharmion Corp.
from 2006 to 2008; Principal at McKinsey & Co., Inc. from 1999 to 2002.
Education includes undergraduate studies at the University of Oxford and a doctorate from Imperial College London.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/04/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Andrew Allen
| Sociétés | Poste | Début |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 07/08/2025 |
Revitope Oncology, Inc.
 Revitope Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops an immunotherapeutic drugs | Fondateur | - |
Peptone Ltd.
 Peptone Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and provides business, domestic software development, data processing, hosting and biotechnology research and development services | Président | 28/09/2023 |
Verge Analytics, Inc.
 Verge Analytics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Directeur/Membre du Conseil | 28/09/2021 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Andrew Allen
| Sociétés | Poste | Fin |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Directeur/Membre du Conseil | 14/11/2025 |
| GRITSTONE BIO, INC. | Directeur Général | 31/12/2024 |
| TCR2 THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/06/2023 |
| SIERRA ONCOLOGY, INC. | Directeur/Membre du Conseil | 01/07/2022 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Andrew Allen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Abbott Laboratories
 Abbott Laboratories Medical SpecialtiesHealth Technology Develops and manufactures medical devices, diagnostic systems, pharmaceuticals & nutritional products | Health Technology |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Sierra Oncology, Inc.
 Sierra Oncology, Inc. BiotechnologyHealth Technology Develops novel therapeutic approaches for cancer and other diseases | Health Technology |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Develops bioinformatics tools to enhance drug development process | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
Verge Analytics, Inc.
Verge Analytics, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Revitope Oncology, Inc.
Revitope Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops an immunotherapeutic drugs | Health Technology |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Develops disruptive cell-based therapies for cancer and other devastating diseases | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Peptone Ltd.
Peptone Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and provides business, domestic software development, data processing, hosting and biotechnology research and development services | Health Technology |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
